Understanding the health effect of a bioactive peptide from egg: A pilot study
Diabetes | Prediabetes | NutritionBioactive peptides derived from food proteins show potential for improving human health. One of such promising peptides is a short tripeptide IRW (made of three amino acids). This is a feasibility study designed to assess the acute effect of IRW for the management of high sugar and blood pressure.
Participants will undergo 4 consecutive treatments of 1 day each (randomly), during which they will consume a standardized breakfast with a smoothie containing a protein powder. Each treatment will be separated by a minimum of 1-week.
Participants in the healthy control group will undergo 1 treatment only (one day).
null
Conditions de participation
-
Sexe:
Female, Male -
Âges admissibles:
18 to 70
Critères de participation
Inclusion Criteria:
Female or male participants aged 18-70 years old.
Living in Edmonton (or Edmonton area/driving distance)
Group at risk of diabetes/having type 2 diabetes: with overweight or obesity and high glucose levels.
Participants with normal weight and normal glucose levels will be eligible for participation.
Exclusion Criteria:
Individuals with a previous history of cardiovascular disease, renal disorder, monogenic dyslipidemia, with endocrine disorders other than type 2 diabetes.
Individuals taking chronic anti-inflammatory drugs (including aspirin, antihistamines and omega-3 supplements).
Pregnant/lactating women.
Individuals who regularly smoke.
Individuals with specific nutritional restrictions (e.g. vegetarianism excluding egg from their diet, vegan or with egg allergy).
Individuals who drink more than 2 alcoholic drinks per day.
Individuals with anemia
Lieu de l'étude
University of Alberta
University of AlbertaEdmonton, Alberta
Canada
Contactez l'équipe d'étude
- Étude parrainée par
- University of Alberta
- Participants recherchés
- Plus d'informations
- ID de l'étude:
Pro00125956